Company & Sponsor Intelligence
CHU de Reims
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials7
Recruiting3
Completed3
Countries1
Therapeutic footprint
alzheimersanxietydepressionepilepsyother_neurologysubstance_use
Indexed studies
NCT07456384Sensory Stimulation Program Delivered by Family Members of Brain-injured Patients in Critical Care: Effect on Relatives' Post-traumatic Stress
anxiety · FranceNA
anxiety · FranceNA
NCT03049436Adapted Physical Activity in a Chemotherapy Ambulatory Care Unit: Feasibility and Impact on Fatigue, Anxiety and Depression in Cancer Patients
depression · FranceUNKNOWN
depression · FranceUNKNOWN
NCT01566071Ability to Drive of Early Stage Alzheimer Disease
alzheimers · FranceNA
alzheimers · FranceNA
NCT07464613Social Cognition in Severe Alcohol Use Disorder
substance_use · FranceNA
substance_use · FranceNA
NCT04647422Social Cognition and Executive Functions in Alcohol Use Disorders - Transverse Study
substance_use · FranceNA
substance_use · FranceNA
NCT03007095Preterm Birth and Social Cognition
other_neurology · FranceNA
other_neurology · FranceNA
NCT04253379Social Cognition in Pediatric Epilepsy
epilepsy · FranceNA
epilepsy · FranceNA
Intelligence layer updated: 2026-10-14 06:11:28.884102+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →